Ligand validation:3A5Y

KAA: 5'-O-[(L-LYSYLAMINO)SULFONYL]ADENOSINE

KAA is a Ligand Of Interest in 3A5Y designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3A5Y_KAA_B_1991	95%	7%	0.074	0.98	2.86	2.1	5	5	2	0	100%	1
3A5Y_KAA_C_1992	95%	6%	0.075	0.98	2.86	2.22	5	5	2	0	100%	1
3A5Y_KAA_D_1993	95%	6%	0.073	0.975	2.85	2.21	6	4	1	0	100%	1
3A5Y_KAA_A_1990	89%	6%	0.092	0.972	2.88	2.19	6	4	2	0	100%	1
3A5Z_KAA_A_990	70%	6%	0.161	0.978	2.87	2.27	6	5	2	0	100%	1
3E9H_KAA_A_2002	96%	8%	0.075	0.983	2.83	1.92	5	8	2	0	100%	1
7F6W_KAA_A_601	95%	62%	0.085	0.989	0.78	0.66	1	1	0	0	100%	0.84
6C86_KAA_A_601	86%	55%	0.094	0.963	0.68	1.05	1	2	1	0	100%	1
6CHD_KAA_A_601	85%	56%	0.117	0.982	0.71	1	1	3	1	0	100%	1
7EA9_KAA_A_601	82%	1%	0.128	0.984	5.3	3.63	13	11	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.